Lumos Diagnostics Holdings Limited (FRA:7YU)

Market Cap	51.26M -50.4%
Revenue (ttm)	11.55M +6.4%
Net Income	-4.33M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	0.0465
Previous Close	0.0465
Day's Range	0.0465 - 0.0465
52-Week Range	0.0385 - 0.1780
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About FRA:7YU

Lumos Diagnostics Holdings Limited develops, manufactures, and distributes diagnostic technologies in the United States. The company offers FebriDx, a point-of-care diagnostic test for acute respiratory infections, and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2018
• Country: Australia
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7YU

Financial Performance

In fiscal year 2026, FRA:7YU's revenue was $13.19 million, an increase of 6.39% compared to the previous year's $12.40 million. Losses were -$4.95 million, -31.06% less than in 2025.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error